India’s New Regime Aims To Build Health Infrastructure But Gives No Boost To Pharma
This article was originally published in PharmAsia News
Executive Summary
The much-watched Union Budget – an annual statement that summarizes the government’s development programs– fell short of expectations for the pharmaceutical industry. But the new government appears keen on developing the health infrastructure and opening up the fledgling health insurance sector to foreign players.